Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families

Human Molecular Genetics

Volumn 21, Issue 13, 2012, Pages 2889-2898

  Osorio, Ana ^a,b   Endt, Daniela ^c   Fernández, Fernando ^a   Eirich, Katharina ^c   De la Hoya, Miguel ^d   Schmutzler, Rita ^e   Caldés, Trinidad ^d   Meindl, Alfons ^f   Schindler, Detlev ^c   Benitez, Javier ^a,b  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER FAMILY; FEMALE; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; ONCOGENE; OVARY CANCER; PREVALENCE; PRIORITY JOURNAL; PUBLICATION; RAD51C GENE; SPAIN;

BREAST NEOPLASMS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETIC VARIATION; HUMANS; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PEDIGREE; SEQUENCE ALIGNMENT;

EID: 84863532805     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/dds115     Document Type: Article

References (31)

1. Diez, O., Osorio, A., Duran, M., Martinez-Ferrandis, J.I., de la Hoya, M., Salazar, R., Vega, A., Campos, B., Rodriguez-Lopez, R., Velasco, E. et al. (2003) Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum. Mutat., 22, 301-312.
2. Osorio, A., Barroso, A., Martinez, B., Cebrian, A., San Roman, J.M., Lobo, F., Robledo, M. and Benitez, J. (2000) Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. Br. J. Cancer, 82, 1266-1270.
3. Antoniou, A.C., Pharoah, P.D., McMullan, G., Day, N.E., Ponder, B.A. and Easton, D. (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 21, 1-18.
4. de la Hoya, M., Perez-Segura, P., Van Orsouw, N., Diaz-Rubio, E. and Caldes, T. (2001) Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene. Int. J. Cancer, 91, 137-140.
5. Borresen, A.L., Andersen, T.I., Garber, J., Barbier-Piraux, N., Thorlacius, S., Eyfjord, J., Ottestad, L., Smith-Sorensen, B., Hovig, E., Malkin, D. et al. (1992) Screening for germ line TP53 mutations in breast cancer patients. Cancer Res., 52, 3234-3236.
6. Lynch, E.D., Ostermeyer, E.A., Lee, M.K., Arena, J.F., Ji, H., Dann, J., Swisshelm, K., Suchard, D., MacLeod, P.M., Kvinnsland, S. et al. (1997) Inherited mutations in PTEN that are associated with breast cancer, Cowden disease, and juvenile polyposis. Am. J. Hum. Genet., 61, 1254- 1260.
7. Meijers-Heijboer, H., van den Ouweland, A., Klijn, J., Wasielewski, M., de Snoo, A., Oldenburg, R., Hollestelle, A., Houben, M., Crepin, E., van Veghel-Plandsoen, M. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
8. Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., North, B., Jayatilake, H., Barfoot, R., Spanova, K. et al. (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat. Genet., 38, 873-875.
9. Seal, S., Thompson, D., Renwick, A., Elliott, A., Kelly, P., Barfoot, R., Chagtai, T., Jayatilake, H., Ahmed, M., Spanova, K. et al. (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat. Genet., 38, 1239-1241.
10. Rahman, N., Seal, S., Thompson, D., Kelly, P., Renwick, A., Elliott, A., Reid, S., Spanova, K., Barfoot, R., Chagtai, T. et al. (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat. Genet., 39, 165-167.
11. Cybulski, C., Wokolorczyk, D., Jakubowska, A., Huzarski, T., Byrski, T., Gronwald, J., Masojc, B., Deebniak, T., Gorski, B., Blecharz, P. et al. (2011) Risk of breast cancer in women with a CHEK2 mutation with and without a family history of breast cancer. J. Clin. Oncol., 29, 3747-3752.
12. Meindl, A., Hellebrand, H., Wiek, C., Erven, V., Wappenschmidt, B., Niederacher, D., Freund, M., Lichtner, P., Hartmann, L., Schaal, H. et al. (2010) Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. Nat. Genet., 42, 410-414.
13. Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F. et al. (2010) Mutation of the RAD51C gene in a Fanconi anemia-like disorder. Nat. Genet., 42, 406-409.
14. Zheng, Y., Zhang, J., Hope, K., Niu, Q., Huo, D. and Olopade, O.I. (2010) Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer. Breast Cancer Res. Treat., 124, 857-861.
15. Clague, J., Wilhoite, G., Adamson, A., Bailis, A., Weitzel, J.N. and Neuhausen, S.L. (2011) RAD51C germline mutations in breast and ovarian cancer cases from high-risk families. PLoS One, 6, e25632.
16. Akbari, M.R., Tonin, P., Foulkes, W.D., Ghadirian, P., Tischkowitz, M. and Narod, S.A. (2010) RAD51C germline mutations in breast and ovarian cancer patients. Breast Cancer Res., 12, 404.
17. Pang, Z., Yao, L., Zhang, J., Ouyang, T., Li, J., Wang, T., Fan, Z., Fan, T., Lin, B. and Xie, Y. (2011) RAD51C germline mutations in Chinese women with familial breast cancer. Breast Cancer Res. Treat., 129, 1019-1020.
18. Pelttari, L.M., Heikkinen, T., Thompson, D., Kallioniemi, A., Schleutker, J., Holli, K., Blomqvist, C., Aittomaki, K., Butzow, R. and Nevanlinna, H. (2011) RAD51C is a susceptibility gene for ovarian cancer. Hum. Mol. Genet., 20, 3278-3288.
19. Romero, A., Perez-Segura, P., Tosar, A., Garcia-Saenz, J.A., Diaz-Rubio, E., Caldes, T. and de la Hoya, M. (2011) A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families. Breast Cancer Res. Treat., 129, 939-946.
20. Vuorela, M., Pylkas, K., Hartikainen, J.M., Sundfeldt, K., Lindblom, A., von Wachenfeldt Wappling, A., Haanpaa, M., Puistola, U., Rosengren, A., Anttila, M. et al. (2011) Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility. Breast Cancer Res. Treat., 130, 1003-1010.
21. Thompson, E.R., Boyle, S.E., Johnson, J., Ryland, G.L., Sawyer, S. and Choong, D.Y., Kconfab, Chenevix-Trench, G., Trainer, A.H., Lindeman, G.J. et al. (2011) Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients. Hum. Mutat., 33, 95-99.
22. Somyajit, K., Subramanya, S. and Nagaraju, G. (2012) Distinct roles of FANCO/RAD51C in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility. J. Biol. Chem., 287, 3366-3380.
23. Kumar, P., Henikoff, S. and Ng, P.C. (2009) Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc., 4, 1073-1081.
24. Adzhubei, I.A., Schmidt, S., Peshkin, L., Ramensky, V.E., Gerasimova, A., Bork, P., Kondrashov, A.S. and Sunyaev, S.R. (2010) A method and server for predicting damaging missense mutations. Nat. Methods, 7, 248-249.
25. Forget, A.L. and Kowalczykowski, S.C. (2010) Single-molecule imaging brings Rad51 nucleoprotein filaments into focus. Trends Cell Biol., 20, 269-276.
26. Leveille, F., Blom, E., Medhurst, A.L., Bier, P., Laghmani el, H., Johnson, M., Rooimans, M.A., Sobeck, A., Waisfisz, Q., Arwert, F. et al. (2004) The Fanconi anemia gene product FANCF is a flexible adaptor protein. J. Biol. Chem., 279, 39421-39430.
27. Beauchamp, N.J., Taybert, J., Champion, M.P., Layet, V., Heinz-Erian, P., Dalton, A., Tanner, M.S., Pronicka, E. and Sharrard, M.J. (2007) High frequency of missense mutations in glycogen storage disease type VI. J. Inherit. Metab. Dis., 30, 722-734.
28. Honrado, E., Osorio, A., Palacios, J. and Benitez, J. (2006) Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations. Oncogene, 25, 5837-5845.
29. de la Hoya, M., Gutierrez-Enriquez, S., Velasco, E., Osorio, A., Sanchez de Abajo, A., Vega, A., Salazar, R., Esteban, E., Llort, G., Gonzalez-Sarmiento, R. et al. (2006) Genomic rearrangements at the BRCA1 locus in Spanish families with breast/ovarian cancer. Clin. Chem., 52, 1480-1485.
30. Gutierrez-Enriquez, S., de la Hoya, M., Martinez-Bouzas, C., Sanchez de Abajo, A., Ramon y Cajal, T., Llort, G., Blanco, I., Beristain, E., Diaz-Rubio, E., Alonso, C. et al. (2007) Screening for large rearrangements of the BRCA2 gene in Spanish families with breast/ovarian cancer. Breast Cancer Res. Treat., 103, 103-107.
31. French, C.A., Masson, J.Y., Griffin, C.S., O'Regan, P., West, S.C. and Thacker, J. (2002) Role of mammalian RAD51L2 (RAD51C) in recombination and genetic stability. J. Biol. Chem., 277, 19322-19330.